⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 19, 2007The Economists Voice

The Case for Public Funding and Public Oversight of Clinical Trials

Tracy R. Lewis Jerome H. Reichman Anthony D. So

View at Publisher

Ask AI

Bookmark

Share

Abstract

Clinical drug trials are public goods and should be publicly funded to avoid undersupply, the suppression of adverse results and other problems, according to Tracy R. Lewis, Jerome H. Reichman and Anthony D. So.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lewis et al. (2007) studied this question.

synapsesocial.com/papers/6a82b368fb68d755121c22df https://doi.org/10.2202/1553-3832.1123

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1The Future of the Euro as a Global CurrencyThe Economists Voice · Sat,
2When Growth Destroys Collateral: Technological Obsolescence and Macroprudential Risk in the AI EraThe Economists Voice · Tue,
3Will the Capital Markets Union Revive European Growth?The Economists Voice · Sat,
4Defence Spending in the Multiannual Financial Framework 2028–2034: More Own Resources but No EU Tax SovereigntyThe Economists Voice · Mon,
5What Makes Switzerland More Successful Economically Than GermanyThe Economists Voice · Fri,

More from The Economists Voice

The Credibility Cost of Scientists’ Political Expression on Social MediaThu,
Cohesion Policy and Economic Growth in EU RegionsTue,
The Future Ratio: A New Metric for Forward-Looking Fiscal Policy in EuropeTue,
The Evolving Dialogue on European DebtWed,
Institutional and Cultural Foundations of Swiss ProsperityFri,